John Shine

Corporate Officer/Principal at The University of New South Wales

78 year

Health Technology

Consumer Services

Government

Profile

John Shine is currently a Professor of Molecular Biology & Medicine at The University of New South Wales.
Previously, he served as the Chairman of CSL Ltd.
from 2011 to 2018.
He also held positions as the Chairman of the National Health & Medical Research Council, Director of G2 Therapies Pty Ltd., Director of The Garvan Institute of Medical Research from 2011 to 2012, Director of Garvan Research Foundation, Member of the Prime Minister's Science, Engineering & Innovation Council, and President of the Museum of Applied Arts & Sciences.

John Shine active positions

Companies	Position	Start
The University of New South Wales	Corporate Officer/Principal	28/10/2010

All active positions of John Shine

Former positions of John Shine

Companies	Position	End
CSL LIMITED	Chairman	16/10/2018
The Garvan Institute of Medical Research The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia.	Director/Board Member	31/12/2011
Museum of Applied Arts & Sciences	President	-
Prime Minister's Science, Engineering & Innovation Council	Corporate Officer/Principal	-
National Health & Medical Research Council	Chairman	-

See the detail of John Shine's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Shine's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
CSL LIMITED	Health Technology

Private companies	6
G2 Therapies Pty Ltd. G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia.	Health Technology
National Health & Medical Research Council	Government
The Garvan Institute of Medical Research The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia.	Commercial Services
Prime Minister's Science, Engineering & Innovation Council
Garvan Research Foundation
Museum of Applied Arts & Sciences

See company connections